-
-
-
-
-
-
-
PDS Biotechnology (PDSB) Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune
-
-
-
-
-
-
-
PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
-
-
-
-
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

